Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors

Overview of attention for article published in BMC Urology, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,773 followers.

RT @SpringerUrology: Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospectiv…

05 Dec 2018

Reply Repost Favourite

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors https://t.co/zdBPrh3D75 via @BioMedCentral #bmcurol #OpenAccess

05 Dec 2018

Reply Repost Favourite